Actively Recruiting
Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells
Led by Hadassah Medical Organization · Updated on 2025-03-19
1
Participants Needed
1
Research Sites
1152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation. The major goal of the project is to develop human iPS cells from existing lines of fibroblasts that were originally donated as clinical grade feeders for the development of clinical grade hESCs. The clinical grade feeders were developed from aborted fetuses, foreskin and umbilical cord.
CONDITIONS
Official Title
Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy adults older than 18 years
You will not qualify if you...
- Not healthy
- Younger than 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hadassah Ein Kerem
Jerusalem, Israel, Israel, 9112100
Actively Recruiting
Research Team
B
Benjamin E Reubinoff, MD PhD
CONTACT
S
Shelly E. Tannenbaum, MSQA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here